Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin Inhale in Non-cystic Fibrosis Bronchiectasis
NCT00930982Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ciprofloxacin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Bayer. Started Jun 2009; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT00930982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930982.